Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Science Requires Open Discourse

Science Requires Open Discourse Opinion EDITORIAL Mitchell H. Katz, MD; Rita F. Redberg, MD, MSc As editors of JAMA Internal Medicine, we strive to publish work Phillip Morris International, the manufacturer of the heat-not- that shines light on and informs use of medical products and burn cigarette tested by Auer and colleagues, recently ap- practices. We recognize that there can be honest differences plied to the US Food and Drug Administration for approval to market in the United States. Because these cigarettes are pro- of opinion and that not all published findings will be success- fully replicated. In addition moted as a safer alternative to smoking ordinary cigarettes, data to our critical appraisal, we on their harmful by-products would undercut the company’s Viewpoint page 7 greatly value our reviewers’ regulatory and marketing strategy. help in identifying any prob- Following publication of the Research Letter by Auer and lems with submitted articles; we welcome Letters to the Edi- colleagues, employees of Phillip Morris International submit- tor, including letters that are highly critical and challenge the ted a Letter to the Editor that is scheduled to be published findings of the work we publish. We also publish replications along with a second critical Letter to http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Science Requires Open Discourse

JAMA Internal Medicine , Volume 178 (1) – Jan 6, 2018

Loading next page...
 
/lp/american-medical-association/science-requires-open-discourse-7DEstX4SVn
Publisher
American Medical Association
Copyright
Copyright 2017 American Medical Association. All Rights Reserved.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2017.5763
Publisher site
See Article on Publisher Site

Abstract

Opinion EDITORIAL Mitchell H. Katz, MD; Rita F. Redberg, MD, MSc As editors of JAMA Internal Medicine, we strive to publish work Phillip Morris International, the manufacturer of the heat-not- that shines light on and informs use of medical products and burn cigarette tested by Auer and colleagues, recently ap- practices. We recognize that there can be honest differences plied to the US Food and Drug Administration for approval to market in the United States. Because these cigarettes are pro- of opinion and that not all published findings will be success- fully replicated. In addition moted as a safer alternative to smoking ordinary cigarettes, data to our critical appraisal, we on their harmful by-products would undercut the company’s Viewpoint page 7 greatly value our reviewers’ regulatory and marketing strategy. help in identifying any prob- Following publication of the Research Letter by Auer and lems with submitted articles; we welcome Letters to the Edi- colleagues, employees of Phillip Morris International submit- tor, including letters that are highly critical and challenge the ted a Letter to the Editor that is scheduled to be published findings of the work we publish. We also publish replications along with a second critical Letter to

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Jan 6, 2018

References